Inactive Instrument

CannAmerica Brands Corp.

CANA

CA13766C1005

Cannamerica Appoints Board Changes

November 06, 2018 at 08:00 am EST

CannAmerica Brands Corp. announced the appointment of Dan Anglin (CEO) and Frank Falconer (COO) to its Board of Directors. Dan Anglin and Frank Falconer co-founded CannAmerica and have been the driving force behind the Company and its success to date.

Latest news about CannAmerica Brands Corp.

CannAmerica Brands Corp. Announces Demise of Dan Anglin, Chief Executive Officer	22-06-24	CI
CannAmerica Brands Corp. Announces Demise of Dan Anglin, Founder and President	22-06-24	CI
CannAmerica Brands Corp. Launches New Product Line	22-05-11	CI
Cannamerica Brands Corp. Appoints Vincent E. Norment to Board of Directors	22-02-14	CI
CannAmerica Brands Corp. Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-28	CI
CannAmerica Brands Corp. Auditor Raises 'Going Concern' Doubt	21-10-04	CI
Cannamerica Brands Corp. Reports Earnings Results for the Full Year Ended March 31, 2021	21-10-04	CI
CannAmerica Brands Corp. Enters into Partnership with the Veteran Sheepdogs of America	21-04-25	CI
CannAmerica Brands Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-26	CI
Cannamerica Brands Corp. Enters into A Non-Binding Letter of Intent ("LOI") for the Purchase of Its Colorado Licensee, Arsenal Oils and Extracts	21-02-24	CI
CannAmerica Brands Corp. entered into letter of intent to acquire Arsenal Oils and Extracts from Rainbow Coleman and Adam Carson for $2 million.	21-02-23	CI
Cannamerica Brands Corp. Signs Exclusive Technology Licensing and Equipment Lease Agreement in Canada	21-02-01	CI
Cannamerica Brands Corp Opens New Facility and Begun Distribution Across Colorado to Dispensaries with Pre-Orders	20-12-18	CI
CannAmerica Brands Corp. Signs Agreement for License Application in Georgia	20-12-15	CI
CannAmerica Brands Corp. Signs Licensing Agreement for Hemp Product Market	20-12-01	CI
Cannamerica Brands Corp. Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-30	CI
CannAmerica Brands Corp. Introduces New Products in Multiple Markets	20-11-11	CI
Cannamerica Brands Corp. Enters New Long Term Licensing Agreement to Distribute Licensed Products in Colorado	20-09-02	CI
Cannamerica Brands Corp. Reports Earnings Results for the Full Year Ended March 31, 2020	20-07-29	CI
CannAmerica Brands Corp. Auditor Raises 'Going Concern' Doubt	20-07-28	CI
CannAmerica Brands Corp. Wins Additional Orders; Announces Board Changes	20-04-14	CI
Cannamerica Brands Corp. Appoints Jason Pinsky as Board of Directors	20-03-09	CI
Cannamerica Brands Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-28	CI
CannAmerica Brands Corp. Launches CannAmerica Clothing Division and E-Commerce Store	20-01-14	CI
Cannamerica Brands Corp. Announces Product Launch in Oklahoma	20-01-09	CI

Chart CannAmerica Brands Corp.

Duration

Period

More charts

Company Profile

CannAmerica Brands Corp. is a Canada-based company that owns a portfolio of brands of medical cannabis and recreational cannabis products. The Company is focused on promoting, marketing and licensing brands through various distribution channels, including dispensaries, wholesalers and distributors. It also offers consulting services. The Company's brands include 8B VII Brands, CANNAMERICA, ANOINTED, LO-HI, LIVE LABS and ARSENAL OILS & EXTRACTS. It has licensees in the states of Colorado, Nevada, Oklahoma and Massachusetts. It offers leaf gummies contain that contain 10 milligram of cannabis extract dosed into delicious fruit gummies of blue raspberry, wild cherry, blue watermelon, pineapple, mango, and strawberry banana. Its subsidiaries include CannAmerica Holdings Corp. and DAFF International, LLC.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+41.06%	6.26B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.95%	4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.36%	3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD	-11.34%	3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.12%	2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.41%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.74%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.67%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-11.32%	1.56B

Alternative Medicine